Cerebral circulation in liver failure: Ohm's law in force

Seminars in Liver Disease

Volumn 16, Issue 3, 1996, Pages 281-292

  Larsen, Fin Stolze ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMMONIA; BARBITURIC ACID DERIVATIVE; CARBON DIOXIDE; MANNITOL; OXYGEN RADICAL; PROSTACYCLIN; THIOPENTAL;

ACIDOSIS; AUTOREGULATION; BLOOD VESSEL REACTIVITY; BRAIN CIRCULATION; BRAIN METABOLISM; CLINICAL TRIAL; COMPUTER ANALYSIS; ECHOENCEPHALOGRAPHY; FORCE; HEMODIALYSIS; HUMAN; HYPOXIA; INFRARED SPECTROSCOPY; INTRACRANIAL HYPERTENSION; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; NONHUMAN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030466051     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007241     Document Type: Review

References (99)

1. Hughes RD, Wendon J, Gimson AE. Acute liver failure. Gut 32 (Suppl):S86-S91, 1991.
2. Tygstrup N, Larsen FS, Hansen BA: The value of high-volume plasmapheresis in acute liver failure. In: Lee W, Williams R (eds). Acute Liver Failure. New York, WB Saunders. 1996. in publication.
3. Posner JB, Plum F: The toxic effect of carbon dioxide and acetazolamide in hepatic encephalopathy. J Clin Invest 39:1246-58, 1960.
4. Fazekas JF, Ticktin HE, Ehrmanntraut WR, Alman RW: Cerebral metabolism in hepatic insufficiency. Am J Med 21:843-9, 1956.
5. Almdal T, Schroeder T, Ranek L: Cerebral blood flow and liver function in patients with encephalopathy due to acute and chronic liver diseases. Scand J Gastroenterol 24:299-303, 1989.
6. Dempsey RJ, Kindt GW: Experimental acute hepatic encephalopathy: relationship of pathological cerebral vasodilation to increased intracranial pressure. Neurosurgery 10:737-41, 1982.
7. Aggarwal S, Kramer D, Yonas H, et al: Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study. Hepatology 19:80-7, 1994.
8. Larsen FS, Olsen KS, Ejlersen E, et al: Cerebral blood flow autoregulation and transcranial Doppler sonography in patients with cirrhosis. Hepatology 22:730-6, 1995.
9. Wendon JA, Harrison PM, Keays R, Williams R: Cerebral blood flow and metabolism in fulminant liver failure. Hepatology 19:1407-13, 1994.
10. Larsen FS, Hansen BA, Ejlersen E, et al: Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure. J Hepatol 23:212-17, 1995.
11. Larsen FS, Pott F, Hansen BA, et al: Transcranial Doppler sonography may predict brain death in patients with fulminant hepatic failure. Transplant Proc 27:3510-11, 1995.
12. Aggarwal S, Yonas H, Scott V, et al: Prognostic value of cerebral hemodynamic and metabolic profiles in patients with fulminant hepatic failure. Liver Transpl Surg 6:435, 1995. Abstract.
13. 2 reactivity in fulminant hepatic failure. J Cereb Blood Flow Metab 15:329-35, 1995.
14. Larsen FS, Ejlersen E, Clemmesen JO, et al: Preservation of cerebral oxidative metabolism in fulminant hepatic failure: An autoregulation study. Liver Transplan Surg 2:348-353, 1996.
15. Ede RJ, Williams RW: Hepatic encephalopathy and cerebral edema. Semin Liver Dis 6:107-18, 1986.
16. Fog M: Cerebral circulation. The reaction of the pial arteries to a fall in blood pressure. Arch Neurol Psychiatry 37:351-64, 1937.
17. Madsen PL, Holm S, Herning M, Lassen NA: Average blood flow and oxygen uptake in the human brain during resting wakefulness: a critical appraisal of the Kety-Schmidt technique. J Cereb Blood Flow Metab 13:646-55, 1993.
18. Lassen NA: Cerebral blood flow and oxygen consumption in man. Physiol Rev 39:138-238, 1959.
19. Paulson OB, Strandgaard S, Edvinsson L: Cerebral autoregulation. Cerebrovasc Brain Metab Rev 2:161-92, 1990.
20. Folkow B: Description of the myogenic hypothesis. Circ Res 15(suppl 1):279-87, 1964.
21. Wang Q, Paulson OB, Lassen NA: Is autoregulation of cerebral blood flow in rats influenced by nitro-L-arginine, a blocker of the synthesis of nitric oxide? Acta Physiol Scand 145:297-8, 1992.
22. Hong KW, Pyo KM, Lee WS, et al: Pharmacological evidence that calcitonin gene-related peptide is implicated in cerebral autoregulation. Am J Physiol 266:H11-H16, 1994.
23. Naylor AR, Miller JD, Edwards CRW, et al: In vivo effect of Calcitonin Gene related Peptide on middle cerebral artery blood flow velocity in humans. J Neurosurg Anesthesiol 4:92-8, 1992.
24. Lam AM, Artu AA: Autoregulation of cerebral blood flow in response to adenosine-induced hypotension in dogs. J Neurosurg Anesthesiol 4:120-7, 1992.
25. 2 saturation of hemoglobin on cerebral vasodilation from hypoxia and hypotension. Am J Physiol 265:H1439-H1443, 1993.
26. 2 reactivity. J Hepatol 25:145-151, 1996.
27. Lassen NA: Brain extracellular pH: the main factor controlling cerebral blood flow. Scand J Clin Lab Invest 22:247-51, 1968.
28. Kety SS, Schmidt CF: The determination of cerebral blood flow in man by the use of nitrous oxide in low concentrations. Am J Physiol 143:53-66, 1945.
29. Schroeder T, Holstein P, Lassen NA, Engell HC: Measurement of cerebral blood flow by intravenous xenon-133 technique and a mobile system. Reproducibility using the Obrist model compared to total curve analysis. Neurol Res 8:237-42, 1986.
30. Larsen FS, Hansen BA, Ejlersen E, et al: Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high-volume plasmapheresis in fulminant hepatic failure. Eur J Gastroenterol Hepatol 8:261-265, 1996.
31. + at critical levels of brain ischemic. Stroke 8:51-7, 1977.
32. Aaslid R, Newell DW, Stooss R, et al: Assessment of cerebral autoregulation dynamics from simultaneous arterial and venous transcranial Doppler recordings in humans. Stroke 22:1148-54, 1991.
33. Jorgensen LG: Transcranial Doppler ultrasound for cerebral perfusion. Acta Physiol Scand 154(suppl 625):1-44, 1995.
34. 2 stimulation. J Neurol Sci 129:120-30, 1995.
35. Giller CA, Bowman G, Dyer H, et al: Cerebral arterial diameters during changes in blood pressure and carbon dioxide during craniotomy. Neurosurgery 32:737-41, 1993.
36. Olsen KS, Svendsen LB, Larsen FS: Validation of transcranial spectroscopy for determination of cerebral blood flow autoregulation. J Neurosurg Anesthesiol In Press.
37. Carter LP, Ersparmer R, Bro WJ: Cortical blood flow: Thermal diffusion vs. isotope clearance. Stroke 12:513-18, 1981.
38. Cruz J: Cerebral oxygenation: monitoring and management. Acta Neurochir Wien 59(suppl):86-90, 1993.
39. Haberl RL, Villringer A, Dimagl U: Application of laser-Doppler flowmetry for cerebral blood flow monitoring in neurological intensive care. Acta Neurochir Suppl Wien 59(suppl):64-8, 1993.
40. Larsen FS, Olsen KS, Hansen BA, et al: Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation. Stroke 25:1985-8, 1994.
41. 2 difference method, Copenhagen, Lægeforeningens Forlag, 1995.
42. Stanley NN, Cherniack NS: Effect of liver failure on the cerebral circulatory and metabolic responses to hypoxia in the goat. Clin Sci Mol Med 50:15-23, 1976.
43. Pott F, Larsen FS, Ejlersen E, et al: Cerebral perfusion during liver transplantation. Clin Physiol 15:282-9, 1995.
44. Tateishi A, Maekaewa T, Soejima Y, et al: Quantitative comparison of carbon dioxide-induced change in cerebral near-infrared spectroscopy versus jugular venous oxygen saturation in adults with acute brain disease. Crit Care Med 23:1734-8, 1995.
45. Prough DS, Pollard V: Cerebral near-infrared spectroscopy: Ready for prime time? Crit Care Med 23:1624-6, 1995.
46. Wickramasinghe YA, Livera LN, Spencer SA, et al: Plethysmographic validation of near infrared spectroscopic monitoring of cerebral blood volume. Arch Dis Child 67:407-11, 1992.
47. Larsen FS, Knudsen GM, Paulson OB, Vilstrup H: Cerebral blood flow autoregulation is absent in rats with thioacetamide-induced hepatic failure. J Hepatol 21:491-5, 1994.
48. Blei AT, Olafsson S, Therrien G, Butterworth RF: Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology 19:1437-44, 1994.
49. Shah V, Webster S, Gottstein J, Blei AT: Reduction of cerebral perfusion precedes rise of intracranial pressure in rats with ischemic fulminant liver failure. Hepatology 17:1117-22, 1993.
50. Srivastava A, Gottstein J, Blei AT: Cerebral blood flow and the hyperdynamic circulation of rats after portacaval anastomosis. J Hepatol 17:15-19, 1993.
51. Hertz MM: Rapid and repetitive measurements of blood flow and oxygen consumption in the rat brain using intraarterial xenon injection. Acta Physiol Scand 101:501-3, 1977.
52. Trewby PN, Hanid MA, Mackenzie RL, et al: Effects of cerebral edema and arterial hypotension on cerebral blood flow in an animal model of hepatic failure. Gut 19:999-1005, 1978.
53. Nickel R, Schummer A, Seiferle E: The Anatomy of the Domestic Animals, vol. I-III. Berlin, Paul Parey Verlag, 1981.
54. Knudsen GM, Poulsen HE, Paulson OB: Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy. No evidence for increased GABA-transport. J Hepatol 6:187-92, 1988.
55. Mullen KD: Evaluation of the suitability of galactosamine-induced fulminant hepatic failure as a model of hepatic encephalopathy in the rat and rabbit. In: Soeters PB, Wilson JHP, Meijer AJ, Hohn E (eds): Advances in Ammonia Metabolism and Hepatic Encephalopathy. Amsterdam, Elsevier Science, 1988, pp 205-11.
56. Poulsen HE, Petersen P, Vilstrup H: Quantitative liver function and morphology after paracetamol administration to rats. Eur J Clin Invest 11:161-4, 1981.
57. Puspok A, Herneth A, Steindl P, Ferenci P: Hepatic encephalopathy in rats with thioacetamide-induced acute liver failure is not mediated by endogenous benzodiazepines. Gastroenterology 105:851-7, 1993.
58. Webster S, Gottstein J, Levy R, Blei AT: Intracranial pressure waves and intracranial hypertension in rats with ischemic fulminant hepatic failure. Hepatology 14:715-20, 1991.
59. Morgan MY, Jakobovits AW, James IM, Sherlock S: Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology 78:663-70, 1980.
60. James LM, Sampson D, Nashat S, Williams HS: Effect of induced metabolic alkalosis in hepatic encephalopathy. Lancet 22:1106-8, 1969.
61. Lockwood AH, Murphy BW, Donnelly KZ, et al: Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology 18:1061-8, 1993.
62. O'Carroll RE, Hayes PC, Ebmeier KP, et al: Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet 337:1250-3, 1991.
63. Knudsen GM: Application of the double-indicator technique for measurement of blood-brain barrier permeability in humans. Cerebrovasc Brain Metab Rev 6:1-30, 1994.
64. Knudsen GM, Schmidt J, Almdal T, et al: Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy. Hepatology 17:987-92, 1993.
65. Rodriguez G, Testa R, Celle G, et al: Reduction of cerebral blood flow in subclinical hepatic encephalopathy and its correlation with plasma-free tryptophan. J Cereb Blood Flow Metab 7:768-72, 1987.
66. Porro GB, Maiolo AT: Cerebral hemodynamics and metabolism in hepatic cirrhosis. Digestion 3:111-21, 1970.
67. Lanthier PL, Morgan MY: Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose. Gut 26:415-20, 1985.
68. Testa R, Rodriguez G, Arvigo F, et al: Cerebral blood flow and plasma free tryptophan in cirrhotics with and without hepatic encephalopathy. Ital J Neurol Sci 10:415-21, 1989.
69. Trzepacz PT, Tarter RE, Shah A, et al: SPECT scan and cognitive findings in subclinical hepatic encephalopathy. J Neuropsychia Clin Neurosci 6:170-5, 1994.
70. Ede RJ, Gove CD, Williams R: Increase cerebral blood flow in fulminant hepatic failure due to paracetamol intoxication. In: Soeters PB, Wilson JHP, Meijer AJ, Holm E (eds): Advances in Ammonia Metabolism. Amsterdam, Elsevier Science, 1988, pp 567-70.
71. Paulson OB, Olesen J, Christensen MS: Restoration of autoregulation of cerebral blood flow by hypocapnia. Neurology 22:286-93, 1972.
72. Keays R, Alexander GJM, Williams R: Intracranial pressure monitoring and cerebral blood flow measurements in fulminant hepatic failure. In: Williams R, Hughes R (eds): Acute Liver Failure. London, Smith Kline Beecham, 1990, pp 45-7.
73. Chen TYZ, Fan F-C, Kim S, et al: Tissue-blood partition coefficient for xenon: Temperature and hematocrit dependence. J Appl Physiol 49:178-83, 1980.
74. Lassen NA: On the regulation of cerebral blood flow in diseases of the brain with special regard to the "Luxury Perfusion Syndrome" of brain tissue, i.e., a syndrome characterized by relative hyperemia or absolute hyperemia of the brain tissue. Prog Brain Res 30:121-4, 1968.
75. Asgeirsson B, Grande P-O, Nordstrom C-H: A new therapy of post-trauma brain edema based on haemodynamic principles for brain volume regulation. Intensive Care Med 20:260-7, 1994.
76. Goh D, Minns RA: Cerebral blood flow velocity monitoring in pyogenic meningitis. Arch Dis Child 68:111-19, 1993.
77. Lassen NA: The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain. Lancet 2:1113-15, 1966.
78. 78a. Munoz SJ, Moritz MJ, Bell R, et al: Factors associated with severe intracranial hypertension in candidates for emergency liver transplantation. Transplantation 55:1071-4, 1993.
79. 78b. Davies MH, Mutimer D, Lowes J, et al: Recovery despite impaired cerebral perfusion in fulminant hepatic failure. Lancet 343:1329-30, 1994.
80. Laursen H: Cerebral vessels and glial cells in liver disease. Acta Neurol Scand 65:381-432, 1982.
81. Hauerberg J, Juhler M, Rasmussen G: Cerebral blood flow autoregulation after experimental subarachnoid hemorrhage during hyperventilation in rats. J Neurosurg Anesthesiol 5:258-63, 1993.
82. Ejlersen E, Larsen FS, Pott F, et al: Hepatectomy corrects cerebral hyperperfusion in fulminant hepatic failure. Transplant Proc 26:1794-5, 1994.
83. Chodobski A, Szmydynger-Chodobska J, Skolasinska K: Effect of ammonia intoxication on cerebral blood flow, its autoregulation and responsiveness to carbon dioxide and papaverine. J Neurol Neurosurg Psychiatry 49:302-9, 1986.
84. 2 responsivity by glutamine synthesis inhibition in hyperammonemic rats. Circ Res 71:1220-30, 1992.
85. Decell MK, Gordon JB, Silver K, Meagher-Villemure K: Fulminant hepatic failure associated with status epilepticus in children: three cases and a review of potential mechanisms. Intensive Care Med 20:375-8, 1994.
86. Kontos HA: Oxygen radicals in cerebral vascular injury. Circ Res 57:508-16, 1985.
87. Muizelaar JP, Marmarou A, Young HF, et al: Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial. J Neurosurg 78:375-82, 1993.
88. Forbes A, Alexander GJM, O'Grady JG, et al: Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure. Hepatology 10:306-10, 1989.
89. Canalese J, Gimson AES, Davis C, et al: Clinical trial. Controlled trial of dexamethasone and mannitol for the cerebral edema of fulminant hepatic failure. Gut 23:625-9, 1982.
90. Davenport A, Will EJ, Davison AM: Adverse effects on cerebral perfusion of prostacyclin administered directly into patients with fulminant hepatic failure and acute renal failure. Nephron 59:449-54, 1991.
91. Villringer A, Dimagl A: Coupling of brain activity and cerebral blood flow: basis of functional neuroimaging. Cerebrovasc Brain Metab Rev 7:240-76, 1995.
92. Keyeaux A, Ochrymowicz-Bemelmanms D, Charlier AA: Induced response to hypercapnia in the two-compartment total cerebral blood volume: influence of brain vascular reserve and flow efficiency. J Cereb Blood Flow Metab 15:1121-31, 1995.
93. Davenport A, Will EJ, Davison AM: Continuous vs. intermittent forms of haemofiltration and/or dialysis in the management of acute renal failure in patients with defective cerebral autoregulation at risk of cerebral edema. Contrib Nephrol 93:225-33, 1991.
94. Davenport A, Will EJ, Davison AM: Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 21:328-38, 1993.
95. Schjcdt FV, Clemmesen JO, Hansen BA, Larsen FS: Cerebral edema during hemodialysis in paracetamol induced fulminant hepatic failure. Scand J Gastroenterol 30:927-8, 1995.
96. Doblar DD, Frenette L, Poplawski S, et al: Middle cerebral artery transcranial Doppler velocity monitoring during orthotopic liver transplantation: changes at reperfusion - a report of six cases. J Clin Anesth 5:479-85, 1993.
97. Larsen FS, Hansen BA, Ejlersen E, et al: Systemic vascular resistance during high-volume plasmapheresis in patients with fulminant hepatic failure: relationship with oxygen consumption. Eur J Gastroenterol Hepatol 7:887-92, 1995.
98. Munoz SJ: Difficult management problems in fulminant hepatic failure. Sem Liver Dis 13:395-413, 1993.
99. Jensen K, Ohrstrom J, Cold GE, Astrup J: The effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension. Acta Neurochir Wien 108:116-21, 1991.